Answer
The selected product is licensed from 3 months of age. Safety and effectiveness have not been established in younger infants.
Sources for this answer
- Tenkasi 400 mg powder for concentrate for solution for infusion — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.